| Year |
Citation |
Score |
| 2022 |
Richert L, Lelièvre JD, Lacabaratz C, Hardel L, Hocini H, Wiedemann A, Lucht F, Poizot-Martin I, Bauduin C, Diallo A, Rieux V, Rouch E, Surenaud M, Lefebvre C, Foucat E, et al. T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial. Journal of Immunology (Baltimore, Md. : 1950). PMID 35613727 DOI: 10.4049/jimmunol.2101076 |
0.31 |
|
| 2020 |
Samri A, Chalouni M, Blanco J, Behrens G, Kelleher P, Massanella M, Ahmad F, Clotet B, Plettenberg A, Katlama C, Richert L, Raffi F, Autran B, Thiebaut R. Influence of the ARV regimen on the early changes in plasma HIV RNA and immune activation at initiation of antiretroviral therapy in naïve HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 33351528 DOI: 10.1097/QAI.0000000000002594 |
0.414 |
|
| 2020 |
Duvignaud A, Lhomme E, Pistone T, Onaisi R, Sitta R, Journot V, Nguyen D, Peiffer-Smadja N, Crémer A, Bouchet S, Darnaud T, Poitrenaud D, Piroth L, Binquet C, Michel JF, et al. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial). Trials. 21: 846. PMID 33050924 DOI: 10.1186/s13063-020-04619-1 |
0.614 |
|
| 2020 |
Diallo MS, Samri A, Charpentier C, Bertine M, Cheynier R, Thiebaut R, Matheron S, Collin F, Braibant M, Candotti D, Brun-Vézinet F, Autran B. A comparison of cell activation, exhaustion and expression of HIV co-receptors and restriction factors in HIV-1 and HIV-2 infected Non Progressors. Aids Research and Human Retroviruses. PMID 33050708 DOI: 10.1089/AID.2020.0084 |
0.415 |
|
| 2020 |
Iannetta M, Isnard S, Manuzak J, Guillerme JB, Notin M, Bailly K, Andrieu M, Amraoui S, Vimeux L, Figueiredo S, Charmeteau-de Muylder B, Vaton L, Hatton EX, Samri A, Autran B, et al. Conventional Dendritic Cells and Slan Monocytes During HIV-2 Infection. Frontiers in Immunology. 11: 1658. PMID 32903610 DOI: 10.3389/Fimmu.2020.01658 |
0.502 |
|
| 2020 |
Capitaine L, Genuer R, Thiébaut R. Random forests for high-dimensional longitudinal data. Statistical Methods in Medical Research. 962280220946080. PMID 32772626 DOI: 10.1177/0962280220946080 |
0.405 |
|
| 2020 |
Lévy Y, Lacabaratz C, Ellefsen-Lavoie K, Stöhr W, Lelièvre JD, Bart PA, Launay O, Weber J, Salzberger B, Wiedemann A, Surenaud M, Koelle DM, Wolf H, Wagner R, Rieux V, et al. Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial. Plos Pathogens. 16: e1008522. PMID 32589686 DOI: 10.1371/Journal.Ppat.1008522 |
0.372 |
|
| 2020 |
Chalouni M, Rodriguez-Centeno J, Samri A, Blanco J, Stella-Ascariz N, Wallet C, Knobel H, Zucman D, Alejos Ferreras B, Autran B, Thiebaut R, Raffi F, Arribas JR. Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals. Plos One. 15: e0230772. PMID 32267847 DOI: 10.1371/Journal.Pone.0230772 |
0.335 |
|
| 2019 |
Lhomme E, Hejblum BP, Lacabaratz C, Wiedemann A, Lelièvre JD, Levy Y, Thiébaut R, Richert L. Analyzing cellular immunogenicity in vaccine clinical trials: a new statistical method including non-specific responses for accurate estimation of vaccine effect. Journal of Immunological Methods. 112711. PMID 31809708 DOI: 10.1016/J.Jim.2019.112711 |
0.305 |
|
| 2019 |
Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiébaut R, Tanser F, Bärnighausen T, Orne-Gliemann J, Pillay D, Dabis F. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa. Journal of the International Aids Society. 22: e25402. PMID 31637821 DOI: 10.1002/Jia2.25402 |
0.811 |
|
| 2019 |
Thiébaut R, Hejblum BP, Hocini H, Bonnabau H, Skinner J, Montes M, Lacabaratz C, Richert L, Palucka K, Banchereau J, Lévy Y. Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals. Frontiers in Immunology. 10: 874. PMID 31105698 DOI: 10.3389/Fimmu.2019.00874 |
0.386 |
|
| 2019 |
Samri A, Charpentier C, Diallo M, Bertine M, Even S, Morin V, Oudin A, Parizot C, Collin G, Hosmalin A, Cheynier R, Thiébaut R, Matheron S, Collin F, Zoorob R, et al. Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection. Plos Pathogens. 15: e1007758. PMID 31095640 DOI: 10.1371/Journal.Ppat.1007758 |
0.525 |
|
| 2019 |
Moore CL, Stöhr W, Crook AM, Richert L, Leliévre JD, Pantaleo G, García F, Vella S, Lévy Y, Thiébaut R, McCormack S. Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions. The Lancet. Hiv. 6: e334-e340. PMID 31047670 DOI: 10.1016/S2352-3018(19)30082-7 |
0.45 |
|
| 2019 |
Hingrat QL, Charpentier C, Ghosn J, Thiébaut R, Peytavin G, Descamps D, Matheron S. New insights are game-changers in HIV-2 disease management. The Lancet. Hiv. 6: e214. PMID 30942186 DOI: 10.1016/S2352-3018(19)30088-8 |
0.432 |
|
| 2019 |
Hocini H, Bonnabau H, Lacabaratz C, Lefebvre C, Tisserand P, Foucat E, Lelièvre JD, Lambotte O, Saez-Cirion A, Versmisse P, Thiébaut R, Lévy Y. HIV controllers have low inflammation associated with a strong HIV-specific immune response in blood. Journal of Virology. PMID 30814287 DOI: 10.1128/Jvi.01690-18 |
0.508 |
|
| 2019 |
Hejblum BP, Alkhassim C, Gottardo R, Caron F, Thiébaut R. Sequential Dirichlet Process Mixtures of Multivariate Skew t-distributions for Model-based Clustering of Flow Cytometry Data The Annals of Applied Statistics. 13: 638-660. DOI: 10.1214/18-Aoas1209 |
0.301 |
|
| 2018 |
Gras L, May M, Ryder LP, Trickey A, Helleberg M, Obel N, Thiebaut R, Guest J, Gill J, Crane H, Lima VD, Monforte AD, Sterling TR, Miro J, Moreno S, et al. Determinants of Restoration of CD4 and CD8 Cell Counts and their Ratio in HIV-1 Positive Individuals with Sustained Virological Suppression on Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30531492 DOI: 10.1097/Qai.0000000000001913 |
0.41 |
|
| 2018 |
Soret P, Avalos M, Wittkop L, Commenges D, Thiébaut R. Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors. Bmc Medical Research Methodology. 18: 159. PMID 30514234 DOI: 10.1186/S12874-018-0609-4 |
0.351 |
|
| 2018 |
Lucar O, Sadjo Diallo M, Bayard C, Samri A, Tarantino N, Debré P, Thiébaut R, Brun-Vézinet F, Matheron S, Cheynier R, Vieillard V. B7-H6-mediated down-regulation of NKp30 in natural killer cells contributes to HIV-2 immune escape. Aids (London, England). PMID 30325780 DOI: 10.1097/Qad.0000000000002061 |
0.515 |
|
| 2018 |
Palich R, Ghosn J, Chaillon A, Boilet V, Nere ML, Chaix ML, Delobel P, Molina JM, Lutch F, Bouchaud O, Rieux V, Thiebaut R, Levy Y, Delaugerre C, Lelievre JD, et al. Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial. Aids (London, England). PMID 30325777 DOI: 10.1097/Qad.0000000000002058 |
0.516 |
|
| 2018 |
Fitzgerald FC, Lhomme E, Harris K, Kenny J, Doyle R, Kityo C, Shaw LB, Abongomera G, Musiime V, Cook A, Brown JR, Brooks A, Owen-Powell E, Gibb DM, Prendergast AJ, et al. Microbial translocation does not drive immune activation in Ugandan children with HIV. The Journal of Infectious Diseases. PMID 30107546 DOI: 10.1093/Infdis/Jiy495 |
0.469 |
|
| 2018 |
Pasin C, Dufour F, Villain L, Zhang H, Thiébaut R. Controlling IL-7 Injections in HIV-Infected Patients. Bulletin of Mathematical Biology. PMID 30073567 DOI: 10.1007/S11538-018-0465-8 |
0.358 |
|
| 2018 |
Larmarange J, Diallo MH, McGrath N, Iwuji C, Plazy M, Thiébaut R, Tanser F, Bärnighausen T, Pillay D, Dabis F, Orne-Gliemann J. The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa). Journal of the International Aids Society. 21: e25128. PMID 30027600 DOI: 10.1002/Jia2.25128 |
0.813 |
|
| 2017 |
Iwuji CC, Orne-Gliemann J, Larmarange J, Balestre E, Thiebaut R, Tanser F, Okesola N, Makowa T, Dreyer J, Herbst K, McGrath N, Bärnighausen T, Boyer S, De Oliveira T, Rekacewicz C, et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. The Lancet. Hiv. PMID 29199100 DOI: 10.1016/S2352-3018(17)30205-9 |
0.769 |
|
| 2017 |
Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, et al. CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study. The Journal of Antimicrobial Chemotherapy. 72: 2869-2878. PMID 29091198 DOI: 10.1093/Jac/Dkx210 |
0.637 |
|
| 2017 |
Thiébaut R, Hue S, Le Marec F, Lelièvre JD, Dupon M, Foucat E, Lazaro E, Dabis F, Duffau P, Wittkop L, Surenaud M, Pellegrin I, Lacabaratz C, Bonnet F, Lévy Y, et al. Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients. Aids (London, England). 31: 2355-2365. PMID 29068834 DOI: 10.1097/Qad.0000000000001628 |
0.594 |
|
| 2017 |
Picat MQ, Pellegrin I, Bitard J, Wittkop L, Proust-Lima C, Liquet B, Moreau JF, Bonnet F, Blanco P, Thiébaut R. Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV Patients. Plos One. 12: e0169164. PMID 28046052 DOI: 10.1371/Journal.Pone.0169164 |
0.444 |
|
| 2017 |
Jarne A, Commenges D, Prague M, Levy Y, Thiébaut R. Modeling CD4 + T cells dynamics in HIV-infected patients receiving repeated cycles of exogenous Interleukin 7 The Annals of Applied Statistics. 11: 1593-1616. DOI: 10.1214/17-Aoas1047 |
0.452 |
|
| 2016 |
Viard JP, Assuied A, Lévy Y, Souberbielle JC, Thiébaut R, Carrat F, Chêne G, Launay O, Richert L. No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults. Plos One. 11: e0168640. PMID 27977797 DOI: 10.1371/Journal.Pone.0168640 |
0.41 |
|
| 2016 |
Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d'Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, et al. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients. Hiv Medicine. PMID 27625009 DOI: 10.1111/Hiv.12389 |
0.493 |
|
| 2016 |
Angin M, Wong G, Papagno L, Versmisse P, David A, Bayard C, Muylder BC, Besseghir A, Thiébaut R, Boufassa F, Pancino G, Sauce D, Lambotte O, Brun-Vézinet F, Matheron S, et al. Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers. Journal of Immunology (Baltimore, Md. : 1950). PMID 27566819 DOI: 10.4049/Jimmunol.1600693 |
0.513 |
|
| 2016 |
Hema MN, Ferry T, Dupon M, Cuzin L, Verdon R, Thiébaut R, Protopopescu C, Leport C, Raffi F, Le Moing V. Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study. Plos One. 11: e0161594. PMID 27548257 DOI: 10.1371/Journal.Pone.0161594 |
0.402 |
|
| 2016 |
Iwuji CC, Orne-Gliemann J, Larmarange J, Okesola N, Tanser F, Thiebaut R, Rekacewicz C, Newell ML, Dabis F. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial. Plos Medicine. 13: e1002107. PMID 27504637 DOI: 10.1371/Journal.Pmed.1002107 |
0.769 |
|
| 2016 |
Prague M, Commenges D, Gran JM, Ledergerber B, Young J, Furrer H, Thiébaut R. Dynamic models for estimating the effect of HAART on CD4 in observational studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort Study. Biometrics. PMID 27461460 DOI: 10.1111/Biom.12564 |
0.389 |
|
| 2016 |
Lhomme E, Richert L, Moodie Z, Pasin C, Kalams SA, Morgan C, Self S, De Rosa SC, Thiébaut R. Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy. Plos One. 11: e0152952. PMID 27124598 DOI: 10.1371/Journal.Pone.0152952 |
0.365 |
|
| 2016 |
Le Grand R, Bosquet N, Dispinseri S, Gosse L, Desjardins D, Shen X, Tolazzi M, Ochsenbauer C, Saidi H, Tomaras G, Prague M, Barnett SW, Thiebaut R, Cope A, Scarlatti G, et al. Superior efficacy of an HIV vaccine combined with ARV prevention in SHIV challenged non-human primates. Journal of Virology. PMID 27009957 DOI: 10.1128/Jvi.00230-16 |
0.36 |
|
| 2016 |
Thiébaut R, Jarne A, Routy JP, Sereti I, Fischl M, Ive P, Speck RF, D'Offizi G, Casari S, Commenges D, Foulkes S, Natarajan V, Croughs T, Delfraissy JF, Tambussi G, et al. Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: 1178-85. PMID 26908786 DOI: 10.1093/Cid/Ciw065 |
0.425 |
|
| 2016 |
Balestre E, Ekouevi DK, Tchounga B, Eholie SP, Messou E, Sawadogo A, Thiébaut R, May MT, Sterne JA, Dabis F. Immunologic response in treatment-naïve HIV-2-infected patients: the IeDEA West Africa cohort. Journal of the International Aids Society. 19: 20044. PMID 26861115 DOI: 10.7448/Ias.19.1.20044 |
0.729 |
|
| 2015 |
Nakagawa F, van Sighem A, Thiebaut R, Smith C, Ratmann O, Cambiano V, Albert J, Amato-Gauci A, Bezemer D, Campbell C, Commenges D, Donoghoe M, Ford D, Kouyos R, Lodwick R, et al. A method to estimate the size and characteristics of HIV-positive populations using an individual-based stochastic simulation model. Epidemiology (Cambridge, Mass.). PMID 26605814 DOI: 10.1097/Ede.0000000000000423 |
0.46 |
|
| 2015 |
Duffau P, Wittkop L, Lazaro E, le Marec F, Cognet C, Blanco P, Moreau JF, Dauchy FA, Cazanave C, Vandenhende MA, Bonnet F, Thiebaut R, Pellegrin I. Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients. Aids (London, England). 29: 2099-108. PMID 26544576 DOI: 10.1097/Qad.0000000000000807 |
0.494 |
|
| 2015 |
Dufouil C, Richert L, Thiébaut R, Bruyand M, Amieva H, Dauchy FA, Dartigues JF, Neau D, Morlat P, Dehail P, Dabis F, Bonnet F, Chêne G. Diabetes and cognitive decline in a French cohort of patients infected with HIV-1. Neurology. 85: 1065-73. PMID 26156515 DOI: 10.1212/Wnl.0000000000001815 |
0.559 |
|
| 2015 |
Geng EH, Neilands TB, Thièbaut R, Bwana MB, Nash D, Moore RD, Wood R, Zannou DM, Althoff KN, Lim PL, Nachega JB, Easterbrook PJ, Kambugu A, Little F, Nakigozi G, et al. CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. International Journal of Epidemiology. 44: 251-63. PMID 25859596 DOI: 10.1093/Ije/Dyu271 |
0.479 |
|
| 2015 |
Brezar V, Ruffin N, Richert L, Surenaud M, Lacabaratz C, Palucka K, Thiébaut R, Banchereau J, Levy Y, Seddiki N. Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity. Plos Pathogens. 11: e1004752. PMID 25816350 DOI: 10.1371/Journal.Ppat.1004752 |
0.441 |
|
| 2015 |
Richert L, Lhomme E, Fagard C, Lévy Y, Chêne G, Thiébaut R. Recent developments in clinical trial designs for HIV vaccine research. Human Vaccines & Immunotherapeutics. 11: 1022-9. PMID 25751670 DOI: 10.1080/21645515.2015.1011974 |
0.425 |
|
| 2014 |
Pantazis N, Porter K, Costagliola D, De Luca A, Ghosn J, Guiguet M, Johnson AM, Kelleher AD, Morrison C, Thiebaut R, Wittkop L, Touloumi G. Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort study. The Lancet. Hiv. 1: e119-26. PMID 26424120 DOI: 10.1016/S2352-3018(14)00002-2 |
0.441 |
|
| 2014 |
Ross E, Tanser F, Pei P, Newell ML, Losina E, Thiebaut R, Weinstein M, Freedberg K, Anglaret X, Scott C, Dabis F, Walensky R. The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials. Hiv Clinical Trials. 15: 185-98. PMID 25350957 DOI: 10.1310/Hct1505-185 |
0.579 |
|
| 2014 |
Thiébaut R, Drylewicz J, Prague M, Lacabaratz C, Beq S, Jarne A, Croughs T, Sekaly RP, Lederman MM, Sereti I, Commenges D, Lévy Y. Quantifying and predicting the effect of exogenous interleukin-7 on CD4+ T cells in HIV-1 infection. Plos Computational Biology. 10: e1003630. PMID 24853554 DOI: 10.1371/Journal.Pcbi.1003630 |
0.404 |
|
| 2014 |
Richert L, Doussau A, Lelièvre JD, Arnold V, Rieux V, Bouakane A, Lévy Y, Chêne G, Thiébaut R. Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design. Trials. 15: 68. PMID 24571662 DOI: 10.1186/1745-6215-15-68 |
0.407 |
|
| 2014 |
Olson AD, Meyer L, Prins M, Thiebaut R, Gurdasani D, Guiguet M, Chaix ML, Amornkul P, Babiker A, Sandhu MS, Porter K. An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration. Plos One. 9: e86719. PMID 24489776 DOI: 10.1371/Journal.Pone.0086719 |
0.506 |
|
| 2013 |
Picat MQ, Lewis J, Musiime V, Prendergast A, Nathoo K, Kekitiinwa A, Nahirya Ntege P, Gibb DM, Thiebaut R, Walker AS, Klein N, Callard R. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. Plos Medicine. 10: e1001542. PMID 24204216 DOI: 10.1371/Journal.Pmed.1001542 |
0.384 |
|
| 2013 |
Touloumi G, Pantazis N, Chaix ML, Bucher HC, Zangerle R, Kran AM, Thiebaut R, Masquelier B, Kucherer C, Monforte Ad, Meyer L, Porter K. Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration. Plos One. 8: e71174. PMID 23936260 DOI: 10.1371/Journal.Pone.0071174 |
0.451 |
|
| 2013 |
Ekouevi DK, Balestre E, Coffie PA, Minta D, Messou E, Sawadogo A, Minga A, Sow PS, Bissagnene E, Eholie SP, Gottlieb GS, Dabis F, Zannou DM, Ahouada C, et al. Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study. Plos One. 8: e66135. PMID 23824279 DOI: 10.1371/journal.pone.0066135 |
0.816 |
|
| 2013 |
Richert L, Hue S, Hocini H, Raimbault M, Lacabaratz C, Surenaud M, Wiedemann A, Tisserand P, Durier C, Salmon D, Lelièvre JD, Chêne G, Thiébaut R, Lévy Y. Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers. Aids (London, England). 27: 1421-31. PMID 23759749 DOI: 10.1097/Qad.0B013E32835F5B60 |
0.473 |
|
| 2013 |
Richert L, Thiebaut R. Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints? Aids (London, England). 27: 1362-5. PMID 23759712 DOI: 10.1097/Qad.0B013E328360D52E |
0.412 |
|
| 2013 |
Prague M, Commenges D, Thiébaut R. Dynamical models of biomarkers and clinical progression for personalized medicine: the HIV context. Advanced Drug Delivery Reviews. 65: 954-965. PMID 23603207 DOI: 10.1016/J.Addr.2013.04.004 |
0.412 |
|
| 2013 |
Thiébaut R, May MT. Mathematical modelling of HIV prevention intervention. Aids (London, England). 27: 475-6. PMID 23291541 DOI: 10.1097/Qad.0B013E32835C1509 |
0.438 |
|
| 2013 |
Thiébaut R, Eholié S, Dabis F. Discussion on the effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults. Aids (London, England). 27: 146-7. PMID 23221429 DOI: 10.1097/Qad.0B013E328359Ab2F |
0.598 |
|
| 2013 |
Wittkop L, Bitard J, Lazaro E, Neau D, Bonnet F, Mercie P, Dupon M, Hessamfar M, Ventura M, Malvy D, Dabis F, Pellegrin JL, Moreau JF, Thiébaut R, Pellegrin I, et al. Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort. The Journal of Infectious Diseases. 207: 622-7. PMID 23204178 DOI: 10.1093/Infdis/Jis732 |
0.499 |
|
| 2012 |
Prague M, Commenges D, Drylewicz J, Thiébaut R. Treatment monitoring of HIV-infected patients based on mechanistic models. Biometrics. 68: 902-11. PMID 22934714 DOI: 10.1111/J.1541-0420.2012.01749.X |
0.375 |
|
| 2012 |
Calmy A, Balestre E, Bonnet F, Boulle A, Sprinz E, Wood R, Delaporte E, Messou E, McIntyre J, El Filali KM, Schechter M, Kumarasamy N, Bangsberg D, McPhail P, Van Der Borght S, et al. Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings. Bmc Infectious Diseases. 12: 147. PMID 22742573 DOI: 10.1186/1471-2334-12-147 |
0.544 |
|
| 2012 |
Lelièvre JD, Melica G, Itti E, Lacabaratz C, Rozlan S, Wiedemann A, Cheynier R, Meignan M, Thiebaut R, Levy Y. Initiation of c-ART in HIV-1 infected patients is associated with a decrease of the metabolic activity of the thymus evaluated using FDG-PET/computed tomography. Journal of Acquired Immune Deficiency Syndromes (1999). 61: 56-63. PMID 22706292 DOI: 10.1097/Qai.0B013E3182615B62 |
0.411 |
|
| 2012 |
Lévy Y, Sereti I, Tambussi G, Routy JP, Lelièvre JD, Delfraissy JF, Molina JM, Fischl M, Goujard C, Rodriguez B, Rouzioux C, Avettand-Fenoël V, Croughs T, Beq S, Morre M, et al. Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 291-300. PMID 22550117 DOI: 10.1093/Cid/Cis383 |
0.481 |
|
| 2012 |
Balestre E, Eholié SP, Lokossue A, Sow PS, Charurat M, Minga A, Drabo J, Dabis F, Ekouevi DK, Thiébaut R. Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa. Aids (London, England). 26: 951-7. PMID 22382142 DOI: 10.1097/Qad.0B013E3283528Ad4 |
0.692 |
|
| 2012 |
Drylewicz J, Commenges D, Thiebaut R. Maximum a Posteriori Estimation in Dynamical Models of Primary HIV Infection Statistical Communications in Infectious Diseases. 4. DOI: 10.1515/1948-4690.1040 |
0.457 |
|
| 2012 |
Levy Y, Thiébaut R, Montes M, Lacabaratz C, Sloan L, Perusat S, Harrod C, Boucherie C, Zurawski S, Richert L, Chêne G, Banchereau J, Palucka K. Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients Retrovirology. 9: 328. DOI: 10.1186/1742-4690-9-S2-P328 |
0.475 |
|
| 2012 |
Thiebaut R, Liquet B, Hocini H, Hue S, Richert L, Raimbault M, Cao KL, Levy Y. A new method for integrated analysis applied to gene expression and cytokines secretion in response to LIPO-5 vaccine in HIV-negative volunteers Retrovirology. 9: 121. DOI: 10.1186/1742-4690-9-S2-P121 |
0.422 |
|
| 2011 |
Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, Zhou J, Cesar C, Brinkhof MW, Mwango A, Balestre E, Carriquiry G, Sirisanthana T, Mukumbi H, Martin JN, Grimsrud A, Bacon M, et al. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. Plos Medicine. 8: e1001111. PMID 22039357 DOI: 10.1371/Journal.Pmed.1001111 |
0.399 |
|
| 2011 |
Li JZ, Paredes R, Ribaudo HJ, Svarovskaia ES, Metzner KJ, Kozal MJ, Hullsiek KH, Balduin M, Jakobsen MR, Geretti AM, Thiebaut R, Ostergaard L, Masquelier B, Johnson JA, Miller MD, et al. Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis. Jama. 305: 1327-35. PMID 21467286 DOI: 10.1001/Jama.2011.375 |
0.417 |
|
| 2011 |
Elemans M, Thiébaut R, Kaur A, Asquith B. Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection. Plos Computational Biology. 7: e1001103. PMID 21408213 DOI: 10.1371/Journal.Pcbi.1001103 |
0.308 |
|
| 2011 |
Thiébaut R, Matheron S, Taieb A, Brun-Vezinet F, Chêne G, Autran B. Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort. Aids (London, England). 25: 865-7. PMID 21358376 DOI: 10.1097/QAD.0b013e328344892e |
0.423 |
|
| 2011 |
Bruyand M, Vandenhende MA, Marcel G, Lazaro E, Lafon ME, Dupon M, Dabis F, Geffard S, Fleury H, Faure-Della Corte M, Bonnet F, Thiebaut R, Garrigue I. CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 50: 177-80. PMID 21126905 DOI: 10.1016/J.Jcv.2010.10.021 |
0.538 |
|
| 2011 |
Guedj J, Thiébaut R, Commenges D. Joint modeling of the clinical progression and of the biomarkers' dynamics using a mechanistic model. Biometrics. 67: 59-66. PMID 20377577 DOI: 10.1111/J.1541-0420.2010.01418.X |
0.432 |
|
| 2011 |
Smith CJ, Sabin CA, Lundgren JD, Thiebaut R, Weber R, Law M, d' AMA,, Kirk O, Friis-Moller N, Phillips A, Reiss P, El SW,, Pradier C, Worm SW. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study (vol 24, pg 1537, 2010) Aids. 25: 883. DOI: 10.1097/Qad.0B013E328343F97F |
0.392 |
|
| 2011 |
Commenges D, Jolly D, Drylewicz J, Putter H, Thiébaut R. Inference in HIV dynamics models via hierarchical likelihood Computational Statistics & Data Analysis. 55: 446-456. DOI: 10.1016/J.Csda.2010.05.012 |
0.396 |
|
| 2010 |
Achhra AC, Zhou J, Dabis F, Pujari S, Thiebaut R, Law MG, Bonnet F. Difference in absolute CD4+ count according to CD4 percentage between Asian and Caucasian HIV-infected patients. Journal of Aids & Clinical Research. 1: 1-4. PMID 21479149 DOI: 10.4172/2155-6113.1000101 |
0.502 |
|
| 2010 |
Smith C, Sabin CA, Lundgren JD, Thiebaut R, Weber R, Law M, Monforte Ad, Kirk O, Friis-Moller N, Phillips A, Reiss P, El Sadr W, Pradier C, Worm SW. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. Aids (London, England). 24: 1537-48. PMID 20453631 DOI: 10.1097/Qad.0B013E32833A0918 |
0.416 |
|
| 2010 |
Drylewicz J, Eholie S, Maiga M, Zannou DM, Sow PS, Ekouevi DK, Peterson K, Bissagnene E, Dabis F, Thiébaut R. First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration. Aids (London, England). 24: 1043-50. PMID 20397306 DOI: 10.1097/Qad.0B013E3283377A06 |
0.718 |
|
| 2010 |
Wittkop L, Smith C, Fox Z, Sabin C, Richert L, Aboulker JP, Phillips A, Chêne G, Babiker A, Thiébaut R. Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field. Clinical Trials (London, England). 7: 19-35. PMID 20156955 DOI: 10.1177/1740774509356117 |
0.375 |
|
| 2010 |
Reigadas S, Andréola ML, Wittkop L, Cosnefroy O, Anies G, Recordon-Pinson P, Thiébaut R, Masquelier B, Fleury H. Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells. The Journal of Antimicrobial Chemotherapy. 65: 434-7. PMID 20051476 DOI: 10.1093/Jac/Dkp473 |
0.462 |
|
| 2010 |
Drylewicz J, Commenges D, Thiébaut R. Score tests for exploring complex models: application to HIV dynamics models. Biometrical Journal. Biometrische Zeitschrift. 52: 10-21. PMID 19937998 DOI: 10.1002/Bimj.200900030 |
0.388 |
|
| 2010 |
Balestre E, Lokossoue A, Eholié SP, Dabis F, Ekouevi DK, Thiébaut R. Comparaison de deux méthodes classiques d’analyse de la réponse immunologique des patients adultes infectés par le VIH, traités par thérapie antirétrovirale (TAR) et suivis dans une cohorte internationale en Afrique de l’Ouest Revue D Epidemiologie Et De Sante Publique. 58. DOI: 10.1016/J.Respe.2010.06.155 |
0.604 |
|
| 2009 |
Déti EK, Thiébaut R, Bonnet F, Lawson-Ayayi S, Dupon M, Neau D, Pellegrin JL, Malvy D, Tchamgoué S, Dabis F, Morlat P. Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France. Hiv Medicine. 11: 308-17. PMID 20002500 DOI: 10.1111/J.1468-1293.2009.00780.X |
0.582 |
|
| 2009 |
Breilh D, Djabarouti S, Trimoulet P, Le Bail B, Dupon M, Ragnaud JM, Fleury H, Saux MC, Thiébaut R, Chêne G, Neau D. Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 428-30. PMID 19858925 DOI: 10.1097/Qai.0B013E3181B62858 |
0.368 |
|
| 2009 |
Bruyand M, Thiébaut R, Lawson-Ayayi S, Joly P, Sasco AJ, Mercié P, Pellegrin JL, Neau D, Dabis F, Morlat P, Chêne G, Bonnet F. Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1109-16. PMID 19705973 DOI: 10.1086/605594 |
0.655 |
|
| 2009 |
Recordon-Pinson P, Anies G, Bruyand M, Neau D, Morlat P, Pellegrin JL, Groppi A, Thiébaut R, Dabis F, Fleury H, Masquelier B. HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity. Antiviral Therapy. 14: 551-6. PMID 19578240 |
0.578 |
|
| 2009 |
Wittkop L, Breilh D, Da Silva D, Duffau P, Mercié P, Raymond I, Anies G, Fleury H, Saux MC, Dabis F, Fagard C, Thiébaut R, Masquelier B, Pellegrin I. Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort. The Journal of Antimicrobial Chemotherapy. 63: 1251-5. PMID 19336453 DOI: 10.1093/Jac/Dkp114 |
0.616 |
|
| 2009 |
Levy Y, Lacabaratz C, Weiss L, Viard JP, Goujard C, Lelièvre JD, Boué F, Molina JM, Rouzioux C, Avettand-Fénoêl V, Croughs T, Beq S, Thiébaut R, Chêne G, Morre M, et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. The Journal of Clinical Investigation. 119: 997-1007. PMID 19287090 DOI: 10.1172/Jci38052 |
0.463 |
|
| 2009 |
Worm SW, Sabin CA, Reiss P, El-Sadr W, Monforte Ad, Pradier C, Thiebaut R, Law M, Rickenbach M, De Wit S, Lundgren JD, Friis-Møller N. Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study. Diabetes Care. 32: 474-80. PMID 19056612 DOI: 10.2337/Dc08-1394 |
0.386 |
|
| 2009 |
Bruyand M, Thiebaut R, Dabis F, Lawson-Ayayi S, Joly P, Sasco A, Mercie P, Pellegrin J, Geffard S, Neau D, Morlat P, Chene G, Bonnet F. Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006) Infectious Agents and Cancer. 4: 1-2. DOI: 10.1186/1750-9378-4-S2-O3 |
0.571 |
|
| 2008 |
Wittkop L, Commenges D, Pellegrin I, Breilh D, Neau D, Lacoste D, Pellegrin JL, Chêne G, Dabis F, Thiébaut R. Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy. Bmc Medical Research Methodology. 8: 68. PMID 18945369 DOI: 10.1186/1471-2288-8-68 |
0.584 |
|
| 2008 |
Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire. Aids (London, England). 22: 1815-20. PMID 18753864 DOI: 10.1097/Qad.0B013E32830B8Ab9 |
0.714 |
|
| 2008 |
Peuchant O, Thiébaut R, Capdepont S, Lavignolle-Aurillac V, Neau D, Morlat P, Dabis F, Fleury H, Masquelier B. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy. Aids (London, England). 22: 1417-23. PMID 18614864 DOI: 10.1097/Qad.0B013E3283034953 |
0.572 |
|
| 2008 |
Jacobsen MC, Thiébaut R, Fisher C, Sefe D, Clapson M, Klein N, Baxendale HE. Pediatric human immunodeficiency virus infection and circulating IgD+ memory B cells. The Journal of Infectious Diseases. 198: 481-5. PMID 18582200 DOI: 10.1086/590215 |
0.337 |
|
| 2008 |
Badiou S, Thiebaut R, Aurillac-Lavignolle V, Dabis F, Laporte F, Cristol JP, Mercie P. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients Journal of Infection. 57: 47-54. PMID 18554723 DOI: 10.1016/J.Jinf.2008.05.007 |
0.555 |
|
| 2008 |
Pellegrin I, Wittkop L, Joubert LM, Neau D, Bollens D, Bonarek M, Girard PM, Fleury H, Winters B, Saux MC, Pellegrin JL, Thiébaut R, Breilh D. Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study). Antiviral Therapy. 13: 271-9. PMID 18505178 |
0.408 |
|
| 2008 |
Richert L, Bouteloup V, Thiébaut R, Chêne G. Methodological issues of non-inferiority trials in HIV-infected patients: a need for consensus? Aids (London, England). 22: 996-7. PMID 18453863 DOI: 10.1097/Qad.0B013E3282Ff6490 |
0.506 |
|
| 2008 |
Drylewicz J, Matheron S, Lazaro E, Damond F, Bonnet F, Simon F, Dabis F, Brun-Vezinet F, Chêne G, Thiébaut R. Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France. Aids (London, England). 22: 457-68. PMID 18301058 DOI: 10.1097/Qad.0B013E3282F4Ddfc |
0.651 |
|
| 2008 |
Duvignac J, Anglaret X, Kpozehouen A, Inwoley A, Seyler C, Toure S, Gourvellec G, Messou E, Gabillard D, Thiébaut R. CD4+ T-lymphocytes natural decrease in HAART-naïve HIV-infected adults in Abidjan. Hiv Clinical Trials. 9: 26-35. PMID 18215979 DOI: 10.1310/Hct0901-26 |
0.36 |
|
| 2008 |
Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. Aids (London, England). 22: 395-402. PMID 18195566 DOI: 10.1097/Qad.0B013E3282F423Dd |
0.555 |
|
| 2008 |
Bruyand M, Thiebaut R, Lawson-Ayayi S, Joly P, Pellegrin J-, Neau D, Uwamaliya B, Morlat P, Chêne G, Dabis F, Bonnet F. Immunodépression, réplication virale et risque de lymphome malin non hodgkinien chez les patients infectés par le VIH (Cohorte ANRS CO3 Aquitaine, 1998–2006) Revue De MéDecine Interne. 29. DOI: 10.1016/J.Revmed.2008.10.029 |
0.462 |
|
| 2007 |
Bonnet F, Chêne G, Thiébaut R, Dupon M, Lawson‐Ayayi S, Pellegrin J, Dabis F, Morlat P. Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004. Hiv Medicine. 8: 547-554. PMID 17944688 DOI: 10.1111/J.1468-1293.2007.00508.X |
0.56 |
|
| 2007 |
Peuchant O, Capdepont S, Ragnaud JM, Aurillac-Lavignolle V, Thiébaut R, Fleury H, Masquelier B. Primary resistance to enfuvirtide (T20) in recently HIV-1 infected, antiretroviral-naive patients from the ANRS Aquitaine Cohort. Antiviral Therapy. 12: 559-62. PMID 17668565 |
0.375 |
|
| 2007 |
Guedj J, Thiébaut R, Commenges D. Practical identifiability of HIV dynamics models. Bulletin of Mathematical Biology. 69: 2493-2513. PMID 17557186 DOI: 10.1007/S11538-007-9228-7 |
0.48 |
|
| 2007 |
Arrivé E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, Leroy V, Perre PV, Rouzioux C, Dabis F. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. International Journal of Epidemiology. 36: 1009-21. PMID 17533166 DOI: 10.1093/Ije/Dym104 |
0.791 |
|
| 2007 |
Guedj J, Thiébaut R, Commenges D. Maximum Likelihood Estimation in Dynamical Models of HIV Biometrics. 63: 1198-1206. PMID 17489970 DOI: 10.1111/J.1541-0420.2007.00812.X |
0.432 |
|
| 2007 |
Le Moing V, Thiébaut R, Chêne G, Sobel A, Massip P, Collin F, Meyohas MC, Al Kaïed F, Leport C, Raffi F, Salamaon R, Moatti JP, Pierret J, Spire B, Brun-Vézinet F, et al. Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs Hiv Medicine. 8: 156-163. PMID 17461859 DOI: 10.1111/J.1468-1293.2007.00446.X |
0.419 |
|
| 2007 |
Bonnet F, Aurillac-Lavignolle V, Breilh D, Thiébaut R, Peuchant E, Bernard N, Lacoste D, Dabis F, Beylot J, Chêne G, Morlat P. Pravastatin in HIV-infected patients treated with protease inhibitors: a placebo-controlled randomized study. Hiv Clinical Trials. 8: 53-60. PMID 17434849 DOI: 10.1310/Hct0801-53 |
0.595 |
|
| 2007 |
Pellegrin I, Breilh D, Coureau G, Boucher S, Neau D, Merel P, Lacoste D, Fleury H, Saux MC, Pellegrin JL, Lazaro E, Dabis F, Thiébaut R. Interpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patients. Antimicrobial Agents and Chemotherapy. 51: 1473-80. PMID 17296739 DOI: 10.1128/Aac.00481-06 |
0.579 |
|
| 2006 |
Duvignac J, Thiébaut R. CD4 natural history and informative censoring in Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes (1999). 43: 380-1. PMID 17079998 DOI: 10.1097/01.Qai.0000242452.12898.Ba |
0.382 |
|
| 2006 |
Lazaro E, Coureau G, Guedj J, Blanco P, Pellegrin I, Commenges D, Dabis F, Moreau JF, Pellegrin JL, Thiébaut R. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection. Antiviral Therapy. 11: 343-50. PMID 16759051 |
0.546 |
|
| 2006 |
Balestre E, Dupon M, Capdepont S, Thiébaut R, Boucher S, Fleury H, Dabis F, Masquelier B. Virological response to HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors-based, tenofovir DF-including regimens in the ANRS Aquitaine Cohort Journal of Clinical Virology. 36: 95-99. PMID 16556509 DOI: 10.1016/J.Jcv.2006.02.002 |
0.594 |
|
| 2006 |
Bonnet F, Balestre E, Thiébaut R, Morlat P, Pellegrin JL, Neau D, Dabis F. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42: 411-7. PMID 16392091 DOI: 10.1086/499054 |
0.58 |
|
| 2006 |
Thiébaut R, Jacqmin-Gadda H, Walker AS, Sabin C, Prins M, Del Amo J, Porter K, Dabis F, Chêne G, Beral V, Coutinho R, Darbyshire JH, Gill N, Lee C, Meyer L, et al. Determinants of response to first HAART regimen in antiretroviral-naïve patients with an estimated time since HIV seroconversion Hiv Medicine. 7: 1-9. PMID 16313286 DOI: 10.1111/J.1468-1293.2005.00332.X |
0.617 |
|
| 2006 |
Thiébaut R, Leroy V, Alioum A, Binquet C, Poizat G, Salmi LR, Gras L, Salamon R, Gilbert R, Chêne G. Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 124: 3-9. PMID 16140453 DOI: 10.1016/J.Ejogrb.2005.07.019 |
0.5 |
|
| 2005 |
Mercié P, Thiébaut R, Aurillac-Lavignolle V, Pellegrin JL, Yvorra-Vives MC, Cipriano C, Neau D, Morlat P, Ragnaud JM, Dupon M, Bonnet F, Lawson-Ayayi S, Malvy D, Roudaut R, Dabis F. Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients Hiv Medicine. 6: 380-387. PMID 16268819 DOI: 10.1111/J.1468-1293.2005.00324.X |
0.606 |
|
| 2005 |
Pellegrin I, Thiébaut R, Blanco P, Viallard JF, Schrive MH, Merel P, Chêne G, Fleury H, Moreau JF, Pellegrin JL. Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters. Journal of Medical Virology. 77: 164-72. PMID 16121362 DOI: 10.1002/Jmv.20452 |
0.461 |
|
| 2005 |
Manuel O, Thiébaut R, Darioli R, Tarr PE. Treatment of dyslipidaemia in HIV-infected persons. Expert Opinion On Pharmacotherapy. 6: 1619-45. PMID 16086650 DOI: 10.1517/14656566.6.10.1619 |
0.476 |
|
| 2005 |
Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palù G, Reiss P, Thiebaut R, Weiland O, Yazdanpanah Y, Zeuzem S. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. Journal of Hepatology. 42: 615-24. PMID 15916745 DOI: 10.1016/J.Jhep.2005.03.003 |
0.449 |
|
| 2005 |
Thiébaut R, Aurillac-Lavignolle V, Bonnet F, Ibrahim N, Cipriano C, Neau D, Dupon M, Dabis F, Mercié P. Change in atherosclerosis progression in HIV infected patients: ANRS Aquitaine Cohort, 1999-2004 Aids. 19: 729-731. PMID 15821400 DOI: 10.1097/01.Aids.0000166097.46940.35 |
0.627 |
|
| 2005 |
Thiébaut R, Pellegrin I, Chêne G, Viallard JF, Fleury H, Moreau JF, Pellegrin JL, Blanco P. Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 x 10(6) cells/l. Aids (London, England). 19: 53-61. PMID 15627033 DOI: 10.1097/00002030-200501030-00006 |
0.381 |
|
| 2005 |
Thiébaut R, Jacqmin-Gadda H, Babiker A, Commenges D. Joint modelling of bivariate longitudinal data with informative dropout and left-censoring, with application to the evolution of CD4+ cell count and HIV RNA viral load in response to treatment of HIV infection. Statistics in Medicine. 24: 65-82. PMID 15523706 DOI: 10.1002/Sim.1923 |
0.497 |
|
| 2005 |
Alioum A, Commenges D, Thiébaut R, Dabis F. A multistate approach for estimating the incidence of human immunodeficiency virus by using data from a prevalent cohort study Journal of the Royal Statistical Society Series C-Applied Statistics. 54: 739-752. DOI: 10.1111/J.1467-9876.2005.00514.X |
0.63 |
|
| 2005 |
Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palù G, Reiss P, Thiebaut R, Weiland O, Yazdanpanah Y, Zeuzem S. Corrigendum to “SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS”[J Hepatol 42 (2005) 615–624] Journal of Hepatology. 43: 1098. DOI: 10.1016/J.Jhep.2005.10.001 |
0.429 |
|
| 2004 |
Bonnet F, Balestre E, Thiébaut R, Mercié P, Dupon M, Morlat P, Dabis F. Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001. Hiv Medicine. 5: 133-9. PMID 15139977 DOI: 10.1111/J.1468-1293.2004.00200.X |
0.479 |
|
| 2004 |
Thiébaut R, Jacqmin-Gadda H. Mixed models for longitudinal left-censored repeated measures. Computer Methods and Programs in Biomedicine. 74: 255-60. PMID 15135576 DOI: 10.1016/J.Cmpb.2003.08.004 |
0.343 |
|
| 2003 |
Thiébaut R, Jacqmin-Gadda H, Journot V, Ferchal F, Rancinan C, Molina JM, Chêne G. Analysis of undetectable HIV RNA using survival analysis: results must be interpreted carefully. Hiv Clinical Trials. 4: 417-20. PMID 14628285 DOI: 10.1310/47L8-Gtk1-R6Q2-4Cuv |
0.451 |
|
| 2003 |
Thiébaut R, Chêne G, Jacqmin-Gadda H, Morlat P, Mercié P, Dupon M, Neau D, Ramaroson H, Dabis F, Salamon R, Beylot J, Le Bras M, Pellegrin JL, Ragnaud JM, Bernard N, et al. Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: The Aquitaine Cohort, 1996-2001 Journal of Acquired Immune Deficiency Syndromes. 33: 380-386. PMID 12843750 DOI: 10.1097/00126334-200307010-00013 |
0.628 |
|
| 2003 |
Thiébaut R, Jacqmin-Gadda H, Leport C, Katlama C, Costagliola D, Le Moing V, Morlat P, Chêne G. Bivariate longitudinal model for the analysis of the evolution of HIV RNA and CD4 cell count in HIV infection taking into account left censoring of HIV RNA measures. Journal of Biopharmaceutical Statistics. 13: 271-82. PMID 12729394 DOI: 10.1081/Bip-120019271 |
0.512 |
|
| 2003 |
Law M, Friis-Møller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Calvo G, El-Sadr W, De Wit S, Sabin CA, Lundgren JD. Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study. Hiv Medicine. 4: 1-10. PMID 12534953 DOI: 10.1046/J.1468-1293.2003.00138.X |
0.35 |
|
| 2003 |
Friis-Møller N, Weber R, Reiss P, Thiebaut R, Kirk O, Monforte Ad, Pradier C, Morfeldt L, Mateu S, Law MMG, El-Sadr W, Wit SD, Sabin C, Phillips AN, Lundgren JD. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study Aids. 17: 1179-1193. DOI: 10.1097/00002030-200305230-00010 |
0.482 |
|
| 2003 |
Bonnet F, Thiébaut R, Chêne G, Neau D, Pellegrin JL, Ceccaldi J, Mercié P, Beylot J, Dabis F, Salamon R, Morlat P, Gecsa. La valeur absolue des lymphocytes CD4+ n'est pas le seul paramètre à considérer pour initier une multithérapie antirétrovirale (MARV) chez les sujets infectés par le VIH : étude de cohorte de 709 patients Revue De MéDecine Interne. 24. DOI: 10.1016/S0248-8663(03)80409-5 |
0.461 |
|
| 2002 |
Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, Del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, et al. Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. International Journal of Epidemiology. 31: 951-8. PMID 12435766 DOI: 10.1093/Ije/31.5.951 |
0.572 |
|
| 2002 |
Bonnet F, Lawson-Ayayi S, Thiébaut R, Ramanampamonjy R, Lacoste D, Bernard N, Malvy D, Bonarek M, Djossou F, Beylot J, Dabis F, Morlat P, Aquitaine GdCdSe. A Cohort Study of Nevirapine Tolerance in Clinical Practice: French Aquitaine Cohort, 1997–1999 Clinical Infectious Diseases. 35: 1231-1237. PMID 12410483 DOI: 10.1086/343046 |
0.483 |
|
| 2002 |
Thiébaut R, Jacqmin-Gadda H, Chêne G, Leport C, Commenges D. Bivariate linear mixed models using SAS proc MIXED Computer Methods and Programs in Biomedicine. 69: 249-256. PMID 12204452 DOI: 10.1016/S0169-2607(02)00017-2 |
0.336 |
|
| 2002 |
Mercié P, Thiébaut R, Lavignolle V, Pellegrin J, Yvorra-Vives M, Morlat P, Ragnaud J, Dupon M, Malvy D, Bellet H, Lawson-Ayayi S, Roudaut R, Dabis F. Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement. Annals of Medicine. 34: 55-63. PMID 12014436 DOI: 10.1080/078538902317338652 |
0.631 |
|
| 2002 |
LeMoing V, Thiébaut R, Chêne G, Leport C, Cailleton V, Michelet C, Fleury H, Herson S, Raffi F. Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen. The Journal of Infectious Diseases. 185: 471-480. PMID 11865399 DOI: 10.1086/338929 |
0.455 |
|
| 2002 |
Bonnet F, Balestre E, Thiébaut R, Mercié P, Ceccaldi J, Dupon M, Malvy D, Witte Sd, Neau D, Bonnal F, Beylot J, Dabis F, Morlat P. Efficacité et tolérance des traitements hypolipémiants (fibrates et statines)chez 136 patients infectés par le VIH sous multithérapies antirétrovirales Revue De MéDecine Interne. 23. DOI: 10.1016/S0248-8663(02)80137-0 |
0.442 |
|
| 2001 |
Malvy D, Thiébaut R, Marimoutou C, Dabis F, Aquitaine GdCDSE. Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997. Journal of the American College of Nutrition. 20: 609-615. PMID 11771676 DOI: 10.1080/07315724.2001.10719065 |
0.707 |
|
| 2001 |
Thiébaut R, Dequae-Merchadou L, Ekouevi DK, Mercié P, Malvy D, Neau D, Dabis F, Chêne G, Salamon R, Lacoste D, Pellegrin I, Dupon M, Moreau JF, Morlat P, Pellegrin JL, et al. Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: The Aquitaine Cohort, France, 1996-99 Hiv Medicine. 2: 84-88. PMID 11737383 DOI: 10.1046/J.1468-1293.2001.00057.X |
0.687 |
|
| 2001 |
Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker S, Beral, Coutinho R, J DA, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, et al. Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts Scopus. PMID 11588510 DOI: 10.1097/00126334-200110010-00008 |
0.596 |
|
| 2001 |
Mercié P, Viallard J, Thiébaut R, Faure I, Rispal P, Leng B, Pellegrin J. Efavirenz-associated breast hypertrophy in HIV-infected patients Aids. 15: 126-129. PMID 11192857 DOI: 10.1097/00002030-200101050-00021 |
0.454 |
|
| 2001 |
Mercié P, Thiébaut R, Lavignolle V, Pellegrin JL, Yvorra-Vives MC, Morlat P, Ragnaud JM, Dupon M, Malvy D, Bellet H, Lawson-Ayayi S, Roudaut R, Dabis F. Mesure de l'épaisseur intima-média carotidienne, marqueur du risque d'athérosclérose, chez les patients infectés par le VIH-1 Revue De MéDecine Interne. 22: 80. DOI: 10.1016/S0248-8663(01)83443-3 |
0.44 |
|
| 2001 |
Mercié P, Lavignolle V, Thiébaut R, Pellegrin JL, Yvorra-Vives MC, Cipriano C, Morlat P, Ragnaud JM, Dupon M, Malvy D, Lawson-Ayayi S, Roudaut R, Dabis F. Augmentation de l'épaisseur intima-média carotidienne chez les patients VIH+:étude longitudinale sur 12 mois Revue De MéDecine Interne. 22. DOI: 10.1016/S0248-8663(01)80117-X |
0.44 |
|
| 2001 |
Mercié P, Lavignolle V, Thiébaut R, Laporte F, Bellet H, Malvy D, Morlat P, Ragnaud JM, Dupon M, Pellegrin JL, Dabis F. Homocystéine, anticorps anti-MDA-LDL modifiéset mesure de l'épaisseur intima-média carotidienne chez les patients VIH+ Revue De MéDecine Interne. 22. DOI: 10.1016/S0248-8663(01)80116-8 |
0.439 |
|
| 2000 |
Jacqmin-Gadda H, Thiébaut R, Chêne G, Commenges D. Analysis of left-censored longitudinal data with application to viral load in HIV infection. Biostatistics. 1: 355-368. PMID 12933561 DOI: 10.1093/Biostatistics/1.4.355 |
0.386 |
|
| 2000 |
Thiébaut R, Daucourt V, Mercié P, Ekouévi DK, Malvy D, Morlat P, Dupon M, Neau D, Farbos S, Marimoutou C, Dabis F. Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 31: 1482-7. PMID 11096016 DOI: 10.1086/317477 |
0.743 |
|
| 2000 |
Mercié P, Tchamgoué S, Thiébaut R, Viallard J, Faure I, Dancourt V, Marimoutou C, Dabis F, Rispal P, Darmon Y, Leng B, Pellegrin J. Atherogen lipid profile in HIV-1-infected patients with lipodystrophy syndrome. European Journal of Internal Medicine. 11: 257-263. PMID 11025250 DOI: 10.1016/S0953-6205(00)00103-5 |
0.75 |
|
| 2000 |
Thiébaut R, Morlat P, Jacqmin-gadda H, Neau D, Mercié P, Dabis F, Chêne G. Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Aids. 14: 971-978. PMID 10853978 DOI: 10.1097/00002030-200005260-00008 |
0.607 |
|
| 2000 |
Thiébaut R, Dabis F, Malvy D, Jacqmin-Gadda H, Mercié P, Valentin VD. Serum triglycerides, HIV infection, and highly active antiretroviral therapy, Aquitaine Cohort, France, 1996 to 1998. Journal of Acquired Immune Deficiency Syndromes. 23: 261-265. DOI: 10.1097/00042560-200003010-00009 |
0.496 |
|
| 1999 |
Thiébaut R, Morlat P, Chêne G, Neau D, Mercié P, Bonnet F, Malvy D, Dabis F, Beylot J. Intérêt de la mesure de la charge virale plasmatique pour la décision de modification thérapeutique: Étude de 773 patients infectés par le VIH Revue De MéDecine Interne. 20. DOI: 10.1016/S0248-8663(00)87580-3 |
0.444 |
|
| 1999 |
Mercié P, Daucourt V, Tchamgoué S, Viallard JF, Faure I, Thiébaut R, Rispal P, Darmon YM, Ayayi S, Dabis F, Leng B, Pellegrin JL. Étude de surveillance des lipodystrophies et des troubles métaboliques chez les patients VIH+. Étude longitudinale: résultats à 6 mois Revue De MéDecine Interne. 20: 563. DOI: 10.1016/S0248-8663(00)87579-7 |
0.45 |
|
| Show low-probability matches. |